Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
about
Adipose stem cells from chronic pancreatitis patients improve mouse and human islet survival and function.Bone-Marrow-Derived Mesenchymal Stromal Cells (MSC) from Diabetic and Nondiabetic Rats Have Similar Therapeutic Potentials.New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement.The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic ReviewMesenchymal Stem Cells as New Therapeutic Approach for Diabetes and Pancreatic Disorders
P2860
Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Multipotent mesenchymal stroma ...... o immunomodulatory properties.
@en
type
label
Multipotent mesenchymal stroma ...... o immunomodulatory properties.
@en
prefLabel
Multipotent mesenchymal stroma ...... o immunomodulatory properties.
@en
P2093
P2860
P50
P1476
Multipotent mesenchymal stroma ...... vo immunomodulatory properties
@en
P2093
Carlos Eduardo Barra Couri
Carolina Caliari-Oliveira
Júlio César Voltarelli
Kalil Willian Alves de Lima
Maria Carolina Oliveira
Patricia Vianna Bonini Palma
P2860
P2888
P356
10.1186/S13287-015-0261-4
P50
P577
2016-01-18T00:00:00Z
P5875
P6179
1033607795